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Abstract
Introduction: Mammographic density has been established as a strong risk factor for breast cancer, primarily using
digitized film mammograms. Full-field digital mammography (FFDM) is replacing film mammography, has different
properties than film, and provides both raw and processed clinical display representation images. We evaluated
and compared FFDM raw and processed breast density measures and their associations with breast cancer.
Methods: A case-control study of 180 cases and 180 controls matched by age, postmenopausal hormone use, and
screening history was conducted. Mammograms were acquired from a General Electric Senographe 2000D FFDM
unit. Percent density (PD) was assessed for each FFDM representation using the operator-assisted Cumulus method.
Reproducibility within image type (n = 80) was assessed using Lin’s concordance correlation coefficient (rc).
Correlation of PD between image representations (n = 360) was evaluated using Pearson’s correlation coefficient (r)
on the continuous measures and the weighted kappa statistic () for quartiles. Conditional logistic regression was
used to estimate odds ratios (ORs) for the PD and breast cancer associations for both image representations with
95% confidence intervals. The area under the receiver operating characteristic curve (AUC) was used to assess the
discriminatory accuracy.
Results: Percent density from the two representations provided similar intra-reader reproducibility (rc= 0.92 for raw
and rc= 0.87 for processed images) and was correlated (r = 0.82 and  = 0.64). When controlling for body mass
index, the associations of quartiles of PD with breast cancer and discriminatory accuracy were similar for the raw
(OR: 1.0 (ref.), 2.6 (1.2 to 5.4), 3.1 (1.4 to 6.8), 4.7 (2.1 to 10.6); AUC = 0.63) and processed representations (OR: 1.0
(ref.), 2.2 (1.1 to 4.1), 2.2 (1.1 to 4.4), 3.1 (1.5 to 6.6); AUC = 0.64).
Conclusions: Percent density measured with an operator-assisted method from raw and processed FFDM images
is reproducible and correlated. Both percent density measures provide similar associations with breast cancer.
Introduction
Increased mammographic breast density is an established
breast cancer risk factor [1-3]. Irrespective of the method
of measurement, the majority of studies have found a
three- to sixfold increased risk of breast cancer in the
highest vs. lowest density categories [2]. The majority of
these studies estimated density from digitized film mam-
mograms. Currently, more than 85 percent of the Mam-
mography Quality Standards Act certified facilities
operate FFDM units [4]. If breast density is to be used in
the clinic for risk assessment and patient management, it
is important to evaluate the performance of density esti-
mated on full-field digital mammography (FFDM).
Film mammography and FFDM have similar diagnostic
accuracy in breast cancer screening [5]. However, images
acquired from these two forms of mammography may not
appear similar on display [6]. FFDM systems can produce
images in both the raw and clinical display representa-
tions, and these display formats differ across manufac-
turers. Clinical display images are processed (that is,
enhanced) with algorithms developed by the respective
manufacturers for improved diagnostic capability. Due to
the size of images and storage considerations, the raw data
is often discarded leaving only this processed data available
for examination. Display variations may influence opera-
tor-assisted measurements of breast density. Currently, it
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is not known which FFDM representation is appropriate
for percent density estimation.
In this report, we investigated the intra-measure repro-
ducibility and the inter-measure correlation of percent
density measures (PD) between raw and processed FFDM
data representations. We also estimated and compared the
associations of PD from both the raw and processed repre-
sentations with breast cancer.
Materials and methods
Study design and population
We used a matched case-control design to examine asso-
ciations between percent density from FFDM and breast
cancer. The study population and data collection methods
were described previously [7]. Briefly, cases were ascer-
tained prospectively and retrospectively from patients with
primary unilateral breast cancer attending the breast
clinics at the H. Lee Moffitt Cancer Center between
September 2007 and July 2011 (n = 180). Retrospective
cases were selected from a record review of patients with
breast cancer who received a four-view screening mam-
mogram on the study FFDM unit at H. Lee Moffitt Cancer
Center prior to or at the time of their breast cancer diag-
nosis. Potential prospective case patients were either
Center breast screening patients without mammograms
from the study unit or screening patients from the
surrounding practices visiting the Center for diagnostic
purposes. All retrospective cases with existing FFDM
images on the study unit with primary unilateral breast
cancer were selected. Prospective cases were recruited and
offered a regular four-view (screening) mammogram from
the study FFDM unit at the time of diagnosis.
Each case was classified into one of three screening-
history categories referenced to the date of their study or
most current FFDM mammogram prior to or at the time
of diagnosis, for control matching purposes: women that
had a history of normal screening 1) within 30 months
prior to their study mammogram (n = 162), 2) outside of
the 30-month window prior to their study mammogram
(n = 13), or 3) women attending their initial screening
mammogram (that is, no screening history) (n = 5). In all
categories, the mammogram closest to diagnosis (including
a mammogram at or immediately after diagnosis but before
treatment) of breast cancer was ascertained for the study
image. We selected the non-cancerous breast image for
examination to avoid cancer present on the images, which
could skew the density measure. Controls without a history
of breast cancer (n = 180) who had archived four-view
screening images acquired with the study FFDM unit were
retrospectively selected from the pool of women under-
going screening mammography at H. Lee Moffitt Cancer
Center between 2007 and 2011. Controls were individually
matched to cases by age (± 2 years), postmenopausal
hormone use and duration (that is, never used or former
use and matched with ± 1 year duration of usage), study
image breast side, and by the three screening-history cate-
gories defined above (that is, referenced relative to their
study image date). For controls meeting the matching cri-
teria, the most current mammogram on the study FFDM
unit was used as the study image. Study data was collected
under a protocol approved by the University of South Flor-
ida, Institutional Review Board (IRB number 104715D),
Tampa, Florida. In accord with this approved protocol
prospective case patients signed written informed consent,
and retrospective data was collected from patients that
signed information release documents previously.
Acquisition of FFDM images and estimation of percent
density
All images were acquired as standard screening, four-
view mammograms. Craniocaudal (CC) views were used
as the study images (that is, the non-cancerous CC view
for cases and the matched side for the controls). All
mammograms were acquired with one General Electric
(GE) Senographe 2000D FFDM unit (General Electric
Medical Systems, Milwaukee, WI, USA). This system
produces data in both the raw and processed image
representations, the latter for clinical display purposes.
The raw images have 14-bit dynamic range for each
pixel (that is, values raging from 0 to 16383), whereas
the processed images have 12-bit dynamic range (that is,
values ranging from 0 to 4095). The raw image pixel
scale can be considered as the X-ray attenuation repre-
sentation, where adipose image regions are bright (large
pixel values) and fibroglandular regions are dark. The
processed images have a reversed intensity scale (and
reduced dynamic range) and appear similar to film
mammograms. Image data was written to DVD storage
in anonymous DICOM format from the GE workstation.
This data was then uploaded to a UNIX-based server.
Percent density (PD) measurements were estimated
from the raw (non-processed images) and processed
representation FFDM images in DICOM format using the
Cumulus3 software (University of Toronto). For a given
representation, the dataset consisting of all cases and
matched control images were de-identified and rando-
mized. The reader (JH) was blinded to the case-control
status and original image identifiers. When using Cumu-
lus, the operator sets window levels and thresholds for
each image to separate the dense from non-dense tissue
and remove the off breast area region from the analysis.
Percent density was calculated as the total dense area
normalized by the total breast area to give the percentage
of dense breast tissue as the PD measure.
Statistical analyses
Patient characteristics and density measures were sum-
marized as either the mean and standard deviation, or
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frequency and percentage, as appropriate. For each PD
measure, quartiles were defined based on the distribu-
tion of that density measure among the control subjects
for all applicable analyses (explicit quartile cutoff values
and ranges are provided in the results below).
Eighty patient study images were selected at random
from the controls to evaluate reproducibility. PD was mea-
sured by a single operator at two time points (separated on
the order of weeks) to assess intra-measure PD reproduci-
bility within a given data representation. Reproducibility
was assessed using Lin’s concordance correlation coeffi-
cient (rc), which measures the strength of the association
between two measures about a line with an intercept of
zero and a slope of one. We also applied linear regression
analysis to evaluate the relationship between repeated
measurements, which was summarized by the slope (m),
intercept (b), and linear correlation coefficient (r).
The associations between the PD values estimated from
the two data representations were assessed with a linear
regression and summarized with m, b, and r. The distribu-
tion quartile concordance between the two PD measure-
ments was evaluated with the weighted kappa statistic ().
The combined case-control dataset was used for both the
regression and  analyses.
Conditional logistic regression was used to model and
compare the association between quartile measures of
PD, and breast cancer status, with the lowest quartile
serving as the reference. Continuous measures (that is,
standard deviations) of PD were also investigated with
conditional logistic regression. The magnitudes of the
associations were summarized by odds ratios (ORs) with
95% confidence intervals (CIs). The findings are
presented for these models: (i) un-adjusted (ii) adjusted
for body mass index (BMI) (kg/m2) only, (iii) adjusted for
both BMI and breast area (or BA, measured in cm2), and
(iv) adjusted for BMI, BA, and menopausal status (pre-
menopausal if they reported experiencing menstrual
cycles, otherwise postmenopausal). In all models, the
ORs for BMI and BA are presented as per distribution
(combined cases and controls) standard deviation
increase. Similarly for the continuous PD measures, ORs
are presented as per standard deviation increase for the
respective FFDM representation. In all applicable models,
we used premenopausal status as the reference for the
menopause binary variable. Additionally as a secondary
means of comparison, the area under the receiver operat-
ing characteristic curve (AUC) was computed as a sum-
mary of the ability of each model to discriminate
between cases and controls. Methods for comparing
correlated AUC [8] were used in this evaluation.
Results
Cases and matched controls were of similar age and
postmenopausal hormone use, as expected due to the
matched design (Table 1). Cases had a higher BMI (26.6
vs. 25.3) and were more likely postmenopausal (79% vs.
73%) than controls. The mean PD was higher for cases
than controls for both FFDM representations (P < 0.01
for the raw data and P < 0.03 for the processed data
from the paired t test). Mean PD quantities were greater
for the processed images than the raw images within
cases (P < 0.11) and controls (P < 0.001), although dif-
ferences were not significant among the cases (Table 1).
The intra-operator reproducibility for PD was high as
evident from the concordance correlation of rc = 0.92 for
the raw images, and rc = 0.87 for the processed images.
The regression analyses from the repeated PD measure-
ments also showed the degree of reproducibility with m
= 0.96 ± 0.05, b = 0.76 and r = 0.92 for the raw images
shown in Figure 1, and m = 0.81 ± 0.05, b = 1.3, and r =
0.89 for the processed images shown in Figure 2. The
similarity between the respective rc and r indicates that
the first and second PD reproducibility measurement dis-
tributions have close agreement in the mean and variance
for a given image representation. However, the deviation
in the processed PD from the ideal regression parameter
values (that is, m = 1 and b = 0) indicates that PD is
better reproduced from the raw images.
The PD measurements from the processed clinical dis-
play images are linearly associated with the PD measure-
ments from the raw images with r = 0.82. As shown in
Figure 3, the processed PD is slightly elevated relative to
the raw PD; the slope is significantly different from unity
with m = 0.74 ± 0.03, and the intercept is significantly dif-
ferent from zero with b = 6.76. When categorizing each of
the PD distributions into their respective quartiles (see
Table 2 for cutoff values and ranges), the relationship
between the two measurements shows moderate agree-
ment, with a weighted kappa () of 0.64 (95% CI: 0.59 to
0.70) [9]. The joint frequency quartile distribution for the
two PD measures is provided and compared in Table 2.
Of the 360 subjects, 217 (60.3%) were classified into the
same quartiles by assessments made on their raw and pro-
cessed images. Of the 143 with discrepant classifications,
131 (91.6%) differed by a single quartile (when applying
the published Boyd categories [10], results were similar
with 66% of the patients classified in the same category
and 32.5% within one category shift, see Additional file 1).
The PD and breast cancer associations for both FFDM
representations are summarized in Table 3 (raw) and
Table 4 (processed). The ORs and AUCs for the associa-
tions of breast cancer with categorical (quartiles of
PD based on controls, provided in Table 2) and con-
tinuous measures of PD (per standard deviation) are pro-
vided. Because our interest is in the performance of the
Cumulus method applied to FFDM image formats, we
focus on the simple BMI-adjusted models for the primary
comparison. The associations and discriminatory accuracy
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Table 1 Participant characteristics by case, control, and combined grouping.










Age 180 58.60/10.46 180 58.53/10.40 360 58.56/10.41 0.232
Menopausal Status 0.049
Postmenopausal 142 78.89% 132 73.33% 274 76.11%
Premenopausal 38 21.11% 48 26.67% 86 23.89%
PMHa 0.297
Never-used 96 53.33% 101 56.11% 197 54.72%
1 - 5 yrs 30 16.67% 27 15.00% 57 15.83%
6 - 10 yrs 18 10.00% 19 10.56% 37 10.28%
11 - 15 yrs 13 7.22% 9 5.00% 22 6.11%
> 15 yrs 23 12.78% 24 13.33% 47 13.06%
BMI (kg/m2)c 179 26.56/4.62 180 25.25/4.25 359 25.90/4.48 0.009
Breast area (cm2) 180 139.01/47.83 180 131.52/40.60 360 135.26/44.46 0.104
PDproc (%) 180 22.48/14.41 180 19.76/12.89 360 21.12/13.72 0.029
PDraw (%) 180 21.33/15.66 180 17.70/14.58 360 19.52/15.22 0.009
aPostmenopausal hormonal (PMH) by years (yrs); bthe mean and standard deviation (SD) for the raw and processed (proc) percentage of breast density measures
(PD), age (years), body mass index (BMI kg/m2) and breast area (cm2) are also provided; cBMI was missing for one case observation; dP values (P) were
determined with the paired t test (continuous variables) or the exact McNemar’s test (binary variables) by comparing the respective case and control quantities.













Figure 1 Reproducibility of percent density from the raw image representation. This shows the percent density measure (PD) applied to a
sample of 80 raw images at two time points labeled as PD1 and PD2, respectively (diamonds) evaluated with this relationship PD2 = m ×PD1 + b,
where m and b are the slope and intercept. The fitted line (solid) was estimated with regression analysis giving: m = 0.96 ± 0.05, b = 0.76, and
linear correlation = 0.92.
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of quartiles of PD from raw (OR: 1.0 (ref.), 2.6 (1.2 to 5.4),
3.1 (1.4 to 6.8), 4.7 (2.1 to 10.6); AUC = 0.63) and
processed images (OR: 1.0 (ref.), 2.2 (1.1 to 4.1), 2.2 (1.1
to 4.4), 3.1 (1.5 to 6.6); AUC = 0.64) with breast cancer
were similar. The associations of continuous PD and
breast cancer for the raw (OR = 1.8 (1.3 to 2.4); AUC =
0.64) and processed (OR = 1.6 (1.2 to 2.2); AUC = 0.63)
images were also similar. In all of the BMI-adjusted
models, the ORs corresponding to the PD and breast
cancer associations were significant (Tables 3 and 4).
The BMI variable had the largest influence on the breast
density associations, as expected [11]. The addition of
breast area and menopausal status together strengthened
(marginally) the PD associations for both representations.
In the fully adjusted continuous PD models, the asso-
ciation of breast cancer with percent density from raw
(OR = 1.8 (1.3 to 2.4)) and processed images (OR = 1.7
(1.2 to 2.3)) showed little difference from the BMI-
adjusted models.
Secondarily, we compared the discriminatory accuracy
(or AUC) of the ability of various models to separate the
cases from the controls (Tables 3 and 4). Within either
representation for both quartile and continuous unad-
justed models, the AUC increase due to the inclusion of
BMI was significant (P < 0.003), whereas the addition of
the other covariates with BMI individually, or simulta-
neously, produced marginal AUC increases (P > 0.20).
However, there was no statistical significant difference in
AUC for PD from raw vs. processed images with breast
cancer for either the unadjusted or adjusted models (P >
0.30).
Discussion
Several of our findings merit particular comment specific
to this FFDM technology. First, PD was reproducible
whether assessed from raw or processed images but repro-
ducibility was slightly higher for the raw representation.
Second, PD assessed from the two FFDM representations
















Figure 2 Reproducibility of percent density from the processed image representation. This shows the percent density measure (PD)
applied to a sample of 80 processed images (same patient samples shown in Figure 1) at two time points labeled as PD1 and PD2, respectively
(diamonds) evaluated with this relationship PD2 = m × PD1 + b, where m and b are the slope and intercept. The fitted line (solid) was estimated
with regression analysis giving: m = 0.81 ± 0.05, b = 1.3, and linear correlation = 0.89.
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was highly correlated, although PD measured from the
processed images was slightly greater than from the raw
images. And, earlier analysis showed that PD estimated
from processed images (same type of FFDM unit used
here) was less than that estimated from film [12]. These
findings suggest that when merging mammograms from
film and FFDM systems for breast density analyses, the
choice of both film vs. FFDM as well as FFDM representa-
tion could impact the study. Much of the discrepancy
between the two image representations of PD was
accounted for by a one quartile shift. However, a small
proportion of samples, approximately 4% (that is 12/360),
showed a large discrepancy of two quartile shifts (Table 2).
Further, our inter-FFDM measure agreement is in the
range of inter-rater PD agreement using various FFDM
models [13]. We demonstrated high intra-rater reproduci-
bility of both the raw and processed FFDM PD, which is
consistent with findings by other groups using different
types of FFDM units [14]. Finally, this work showed that
















Figure 3 Comparison of percent density from the raw and processed images. This plot shows the relation between the percent density
measure (PD) applied to the raw and processed data (diamonds) for the entire case-control dataset evaluated with this relationship PDprocessed =
m × PDraw + b, where m and b are the slope and intercept. The fitted regression line (solid) shows the processed PD as a linear function of the
raw PD giving: m = 0.74 ± 0.03, b = 6.76, and linear correlation = 0.82.
Table 2 Joint frequency quartile distribution for the
number of observations (n) per-quartile for the percent
density measurements (PD) from the raw (vertical) and
processed (horizontal) image representations.
PD (processed)
PD (raw) Quartile 1 Quartile 2 Quartile 3 Quartile 4 n
[0.0, 9.2) [9.2, 18.1) [18.1, 26.3) [26.3, 100)
Quartile 1 52 16 2† 1† 71
[0.0, 5.5)
Quartile 2 19 51 21 3† 94
[5.5, 14.7)
Quartile 3 3† 28 40 21 92
[14.7, 26.9)
Quartile 4 1† 2† 26 74 103
[26.9, 100)
n 75 97 89 99 360
PD quartile ranges and cutoff values (corresponding to those used in Tables 3
and 4) are provided under the quartile headings. †Observations that
experienced two inter-representation quartile shifts (that is, 12/360 or
approximately 4% of the observations).
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PD estimated from either representation was associated
with breast cancer.
The inter-FFDM representation differences in our
findings may be in part due to the pixel dynamic range
compression (14 to 12 bit) or the two-stage mapping
(that is, the mapping applied by the manufacturer) used
to form the processed images from the raw images [15].
The detector response is linear in X-ray exposure for
this system over a wide range of energies [16], which
may also influence the raw image display. These differ-
ences may also be due to operator preference or natural
variation (that is, each image requires its own window
level and threshold adjustments). Because there are rela-
tively few FFDM reports evaluating PD from FFDM,
the generality of our findings will require further
investigations.
Table 3 Associations of categorical and continuous percent density analysis from raw full-field digital mammography









BMI, BA adjusted OR
(95% CI)
BMI, BA, menopause adjusted OR
(95% CI)
1 26 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.)
2 49 2.21 (1.07, 4.55) 2.55 (1.20, 5.42) 2.60 (1.21, 5.55) 2.83 (1.30, 6.16)
3 47 2.17 (1.07, 4.40) 3.12 (1.44, 6.76) 3.15 (1.45, 6.84) 3.45 (1.55, 7.65)
4 58 2.70 (1.32, 5.49) 4.69 (2.08, 10.58) 4.85 (2.13, 11.07) 5.17 (2.24, 11.96)
BMIa n/a 1.56 (1.22, 1.99) 1.49 (1.13, 1.97) 1.46 (1.10, 1.93)
BAa n/a n/a 1.09 (0.83, 1.44) 1.11 (0.84, 1.48)
Menopauseb n/a n/a n/a 2.42 (1.00, 5.86)
AUCc 0.568 0.631 0.634 0.641




BMI, BA adjusted OR
(95% CI)
BMI, BA, menopause adjusted OR
(95% CI)
PDa 1.38 (1.07, 1.77) 1.76 (1.31, 2.37) 1.79 (1.33, 2.43) 1.79 (1.32, 2.42)
BMIa n/a 1.60 (1.25, 2.06) 1.52 (1.15, 2.01) 1.48 (1.12, 1.97)
BAa n/a n/a 1.12 (0.85, 1.48) 1.13 (0.85, 1.50)
Menopauseb n/a n/a n/a 2.06 (0.87, 4.89)
AUCc 0.571 0.638 0.641 0.655
aThe ORs for BMI (kg/m2) and BA (cm2), and PD (continuous models) are cited in per standard deviation increase; bfor the binary menopausal variable, pre-
menopausal status is the reference; cAUC is a measure of discriminatory accuracy. AUC, area under the receiver operating characteristic curve; BA, breast area;
BMI, body mass index; CI, confidence interval; PD, percent density; OR, odds ratio.
Table 4 Associations of categorical and continuous percent density analysis from processed (proc) full-field digital









BMI, BA adjusted OR
(95% CI)
BMI, BA, menopause adjusted
OR (95% CI)
1 30 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.)
2 52 1.70 (0.93, 3.13) 2.16 (1.13, 4.12) 2.24 (1.16, 4.30) 2.59 (1.32, 5.09)
3 44 1.51 (0.81, 2.81) 2.22 (1.11, 4.44) 2.35 (1.16, 4.77) 2.70 (1.30, 5.62)
4 54 1.90 (0.98, 3.67) 3.14 (1.49, 6.60) 3.42 (1.59, 7.39) 3.99 (1.80, 8.84)
BMIa n/a 1.50 (1.18, 1.90) 1.41 (1.08, 1.84) 1.39 (1.06, 1.81)
BAa n/a n/a 1.14 (0.86, 1.51) 1.18 (0.89, 1.57)
Menopauseb n/a n/a n/a 2.82 (1.16, 6.84)
AUCc 0.556 0.636 0.638 0.647




BMI, BA adjusted OR
(95% CI)
BMI, BA, menopause adjusted OR
(95% CI)
PDa 1.32 (1.02, 1.69) 1.63 (1.22, 2.18) 1.67 (1.24, 2.25) 1.68 (1.24, 2.28)
BMIa n/a 1.53 (1.20, 1.94) 1.45 (1.10, 1.89) 1.42 (1.08, 1.86)
BAa n/a n/a 1.13 (0.85, 1.48) 1.14 (0.86, 1.51)
Menopauseb n/a n/a n/a 2.19 (0.93, 5.19)
AUCc 0.550 0.628 0.635 0.643
aThe ORs for BMI (kg/m2) and BA (cm2), and PD (continuous models) are cited in per standard deviation increase; bfor the binary menopausal variable, pre-
menopausal status is the reference; cAUC is a measure of discriminatory accuracy. AUC, area under the receiver operating characteristic curve; BA, breast area;
BMI, body mass index; CI, confidence interval; PD, percent density; OR, odds ratio.
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The present results should be interpreted in light of
certain limitations and qualifications. Limitations of the
study include the relatively limited number of cases and
controls, emphasizing the importance of replicating
these findings in larger studies. Also, the use of mam-
mograms at the time of diagnosis limits our ability to
draw additional conclusions regarding temporality and
risk. And, we were not able to examine or adjust for the
perimenopausal category within menopausal status, due
to the limited nature of the question; however, this
should not influence the comparison between the two
density measures. These findings apply to one specific
FFDM design and to a Cumulus operator with consider-
able experience and preferences. Therefore, it will be
necessary to conduct similar research on other FFDM
technologies with multiple operators and larger datasets
to ensure our results generalize. Similarly, the operator
was not a clinician, and our results strictly apply in the
research environment and not to the clinical setting per
se. Although given an equally skilled operator, we would
expect the findings to theoretically translate to the
clinic. The detector size for the FFDM design (that is,
the earliest FFDM technology) used in our study pre-
cludes its use on women with large breasts with one
exposure [6], limiting the range of breast sizes for the
cases and controls included in the study [7] and conse-
quently our generalizability to women with large breasts.
Our findings will require replication on newer FFDM
models that do not have the size limitation. We
observed slightly higher reproducibility in the analysis of
the raw data than processed data, but this may reflect
that the operator has more experience labeling raw data
than processed data rather than any true difference. The
reproducibility analysis was restricted to control images,
which should not limit generalization because there are
not large differences in the unadjusted case-control PD
distributions. Moreover from our operator’s experience,
the very low-density images, which are less prevalent in
cases, are more difficult to label (that is, in these situa-
tions the operator may perceive a range of acceptable
control settings before the density estimation is per-
formed) than high-density images. The reproducibility
analysis was performed over a short time period, which
could result in higher reproducibility compared to a
longer span between evaluations. Finally, we did not
have corresponding mammograms from film mammo-
graphy units to serve as comparison to the raw and pro-
cessed FFDM representations.
The Cumulus software was developed for digitized film
data applications, not for FFDM. The Cumulus3 operat-
ing instructions indicate that the input data scale should
parallel that of the display representation images (that is,
larger pixel values should correspond with radiographi-
cally dense or bright image regions). It should be noted,
the pixel scale is reversed for our raw images (that is, lar-
ger values corresponded with fatty area). This suggests
that the raw images from this specific mammography
unit are in the incorrect format and will not display
properly within the Cumulus3 interface. To the contrary,
we did not experience any difficulty reading the raw
images without additional preparation. This raw image
pixel scale was automatically inverted (within Cumulus)
so that adipose regions were dark and glandular regions
bright when reading the raw images into the Cumulus
environment. Because we are uncertain as to why the
raw images displayed properly within the Cumulus3
interface, in conflict with operating instructions, this
work should be replicated on both similar and different
FFDM designs as well. Notwithstanding these artifacts,
the comparisons and findings presented in this report
are internally valid.
Conclusions
In summary, PD from the two FFDM representations
was reproducible and correlated. Further, the breast
cancer associations were similar across the data repre-
sentations and agree with those reported previously
[2]. However, the raw data representation provided
slightly better reproducibility. Thus, the raw data may
be preferable for PD applications when possible.
Although these results are encouraging, additional eva-
luation of prospective and larger study populations,
operators, and system designs is required to confirm
our findings.
Additional material
Additional file 1: Table S1. This table provides the joint frequency
distribution for the number of observations (n) per-Boyd acategory for
the percent density measurements (PD) from the raw (vertical) and
processed (horizontal) image representations.
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